The CATHERINE trial begins as the first clinical trial of an innovative CAR-T therapy that triggers a dual anti-tumour response in HER2+ solid tumours

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

2 months ago
CAR-T therapy, HER2, p95HER2, TECH2Me, HER2+ solid tumours

After more than a decade of research, a new-generation CAR-T therapy developed by VHIO, in collaboration with the Hospital del Mar Research Institute, has been administered to patients for the first t...

Gyala Therapeutics initiates Phase I/IIa clinical trial of a CAR-T cell therapy for acute leukemias with limited treatment options

by Gyala Therapeutics

4 months ago
GYA01, CD84 protein, CAR-T therapy, Gyala Therapeutics, T-cell acute lymphoblastic leukemia (T-ALL), Acute myeloid leukemia (AML)

A CAR-T therapy targeting the CD84 protein—an emerging therapeutic target in hematologic malignancies characterized by its high expression in leukemic cells— will be evaluated for the first time

Vall d’Hebron shows long-term safety of CAR-T therapy in aggressive lymphoma patients

by VHIO

1 year ago
CAR-T therapy, B-cell non-Hodgkin’s lymphoma

The results show the need for continuous monitoring of patients to detect and manage possible adverse effects occurring months and years after treatment.

Spanish researchers to design proteins using AI to make advanced therapies more efficient

by INTEGRA

2 years ago
CAR-T therapy, VIVEbiotech, Integra Therapeutics, OneChain Immunotherapeutics, UPF, IBMB-CSIC, CIEMAT, hematopoietic stem cell

Researchers have joined forces to design using artificial intelligence and produce next-generation viral particles to be applied in advanced therapies. These particles can be used in immunotherapies, ...

Immuneel Therapeutics, Hospital Clínic de Barcelona & IDIBAPS Announce a Strategic collaboration & a License Agreement

by Fundació Clínic per a la Recerca Biomèdica

6 years ago
Immuneel Therapeutics, Hospital Clínic, IDIBAPS, leukemia, CAR-T therapy

Immuneel Therapeutics Private Limited (Immuneel) today announced that it has entered into a multi-asset collaboration and licensing agreement with Hospital Clínic de Barcelona (HCB) and Institut d’...